NICE
NICE Ltd.
NICE offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
PLTR
Palantir Technologies Inc.
PLTR has the edge over NICE overall, supported by stronger fundamentals and stronger modeled upside.
NICE Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Healthy | |
| Strong |
NICE's revenue, profitability, cash flow and balance sheet are all currently healthy.
PLTR Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
PLTR's revenue, profitability, cash flow and balance sheet are all currently strong.
NICE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 14x | $94.12 | — |
| Cheap | 17x | $116 | +23% |
| Fair | 49x | $341 | +263% |
| Expensive | 76x | $522 | +454% |
Historical ranges are pointers, not guarantees.
NICE's PE is in its cheap range at 14x.
PLTR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 75x | $172 | — |
| Current | 120x | $172 | — |
| Cheap | 165x | $236 | +37% |
| Fair | 251x | $359 | +109% |
| Expensive | 452x | $646 | +277% |
Historical ranges are pointers, not guarantees.
PLTR has the edge over NICE in the historical PE scenario, which offers more potential upside but is not a forecast.
NICE Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for NICE, with profitability holding steady.
PLTR Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| Moderate |
PLTR has the edge over NICE on the outlook, with more favorable profitability expectations.
NICE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $6.90 | -18% |
| Q1 2026 | $8.43 | +18% |
| Q4 2025 | $9.67 | +43% |
| Q3 2025 | $8.80 | +36% |
| Q2 2025 | $8.37 | +40% |
| Q1 2025 | $7.17 | +29% |
| Q4 2024 | $6.76 | +33% |
| Q3 2024 | $6.46 | +31% |
NICE earned $6.90 per share over the past year, down 18% from the year before.
PLTR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.30 | +61% |
| Q3 2026 | $1.43 | +240% |
| Q2 2026 | $1.17 | +290% |
| Q1 2026 | $0.89 | +287% |
| Q4 2025 | $0.63 | +232% |
| Q3 2025 | $0.42 | +110% |
| Q2 2025 | $0.30 | +76% |
| Q1 2025 | $0.23 | +92% |
| Q4 2024 | $0.19 | +111% |
PLTR has the edge over NICE on earnings, with more consistent year-over-year improvement.
NICE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $795.7M | +9.5% |
| Q1 2026 | $766.5M | +9.5% |
| Q4 2025 | $786.5M | +9% |
| Q3 2025 | $732M | +6.1% |
| Q2 2025 | $726.7M | +9.4% |
| Q1 2025 | $700.2M | +6.2% |
| Q4 2024 | $721.6M | +16% |
| Q3 2024 | $690M | +15% |
NICE's revenue has grown year over year every quarter since late 2020: $796M last quarter, up 9.5% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 14% | -8.3 points |
| Q1 2026 | 16% | -4.7 points |
| Q4 2025 | 22% | +1 points |
| Q3 2025 | 22% | +1.5 points |
| Q2 2025 | 22% | +2.7 points |
| Q1 2025 | 21% | +2.7 points |
| Q4 2024 | 21% | +1.7 points |
| Q3 2024 | 20% | +1.6 points |
NICE's operating margin was 14% last quarter, down 8.3 points from the same quarter a year ago.
PLTR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.3B | +96% |
| Q2 2026 | $1.9B | +93% |
| Q1 2026 | $1.6B | +85% |
| Q4 2025 | $1.4B | +70% |
| Q3 2025 | $1.2B | +63% |
| Q2 2025 | $1B | +48% |
| Q1 2025 | $883.9M | +39% |
| Q4 2024 | $827.5M | +36% |
PLTR has the edge over NICE on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 47% | +14 points |
| Q2 2026 | 47% | +20 points |
| Q1 2026 | 46% | +26 points |
| Q4 2025 | 41% | +40 points |
| Q3 2025 | 33% | +18 points |
| Q2 2025 | 27% | +11 points |
| Q1 2025 | 20% | +7.2 points |
| Q4 2024 | 1.3% | -9.5 points |
PLTR has the edge over NICE on profitability, with a higher operating margin.
NICE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $117.3M | +204% |
| Q1 2026 | $169.4M | -36% |
| Q4 2025 | $156M | -31% |
| Q3 2025 | $163.6M | +24% |
| Q2 2025 | $38.6M | -74% |
| Q1 2025 | $264.6M | +16% |
| Q4 2024 | $225.1M | +40% |
| Q3 2024 | $131.7M | +28% |
NICE generated $606M in free cash flow over the past year, down 8.2% from the year before.
PLTR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.2B | +139% |
| Q2 2026 | $1.2B | +126% |
| Q1 2026 | $891.8M | +193% |
| Q4 2025 | $764M | +67% |
| Q3 2025 | $500.9M | +20% |
| Q2 2025 | $531.6M | +276% |
| Q1 2025 | $304.1M | +140% |
| Q4 2024 | $457.2M | +54% |
PLTR has the edge over NICE on cash flow, with more consistent year-over-year improvement.
NICE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2% | -1.2M shares |
| 1 year | -6% | -3.8M shares |
| 3 years | -11% | -7M shares |
| 5 years | -11% | -7.1M shares |
| Available history | -8.7% | -5.7M shares |
NICE has the edge over PLTR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $60.8M |
| Q1 2026 | $252.6M |
| Q4 2025 | $165.2M |
| Q3 2025 | $40.6M |
| Q2 2025 | $30.8M |
| Q1 2025 | $252.3M |
| Q4 2024 | $95.2M |
| Q3 2024 | $86.4M |
NICE spent $519M buying back its own shares over the past year, up 12% from the year before.
PLTR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +5.2M shares |
| 1 year | +0.1% | +2.9M shares |
| 3 years | +11% | +248M shares |
| 5 years | +31% | +610M shares |
| Available history | +184% | +1.7B shares |
PLTR has 2.6B diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | $19.2M |
| Q3 2025 | $19.2M |
| Q2 2025 | $18.6M |
| Q1 2025 | $18M |
| Q4 2024 | $18.6M |
| Q3 2024 | $18.9M |
| Q2 2024 | $17.7M |
| Q1 2024 | $9M |
NICE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -0.3x | Net Cash |
| Q1 2026 | -0.2x | Net Cash |
| Q4 2025 | -0.2x | Net Cash |
| Q3 2025 | -0.4x | Net Cash |
| Q2 2025 | 0.0x | Very low |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | 0.1x | Very low |
| Q3 2024 | -0.1x | Net Cash |
NICE has more cash than debt.
PLTR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.1x | Net Cash |
| Q2 2026 | -0.8x | Net Cash |
| Q1 2026 | -1.1x | Net Cash |
| Q4 2025 | -1.0x | Net Cash |
| Q3 2025 | -1.9x | Net Cash |
| Q2 2025 | -1.6x | Net Cash |
| Q1 2025 | -2.3x | Net Cash |
| Q4 2024 | -6.1x | Net Cash |
PLTR has the edge over NICE on leverage, with a lower net debt burden relative to earnings.
NICE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 42.9 | Neutral |
| Stochastic | 24.3 | Neutral |
NICE's weekly RSI is 43 (neutral) and its Stochastic is 24 (neutral).
PLTR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.4 | Neutral |
| Stochastic | 47.4 | Neutral |
PLTR's weekly RSI is 51 (neutral) and its Stochastic is 47 (neutral).
NICE PE vs Technology Sector
| Metric | NICE | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 28x | 51% below |
| PE % | 13 | 35 | 22 pts below |
NICE has the edge over PLTR on valuation relative to its sector.
PLTR PE vs Technology Sector
| Metric | PLTR | Sector median | Relative |
|---|---|---|---|
| PE | 120x | 28x | 331% above |
| PE % | 1 | 38 | 37 pts below |
PLTR is trading at 120x earnings, a 331% premium to the Technology sector's median of 28x.
NICE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $110.2 | 15% below |
| 20 week MA | $104.5 | 9.9% below |
| 50 week MA | $105.3 | 11% below |
| 100 week MA | $128.5 | 27% below |
| 200 week MA | $162.8 | 42% below |
NICE is in a downtrend: it's below all five of its weekly moving averages, and 42% below its 200-week average.
PLTR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $185.8 | 7.6% below |
| 20 week MA | $167.6 | 2.4% above |
| 50 week MA | $157.1 | 9.2% above |
| 100 week MA | $143.8 | 19% above |
| 200 week MA | $83.3 | 106% above |
PLTR has the edge over NICE on trend strength, trading above more of its moving averages.
NICE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $156.3 | $279.8 | +79% |
| 2021 | $279.8 | $306.4 | +9.5% |
| 2022 | $306.4 | $194.7 | -36% |
| 2023 | $194.7 | $199.5 | +2.5% |
| 2024 | $199.5 | $173.5 | -13% |
| 2025 | $173.5 | $112.7 | -35% |
| 2026 YTD | $112.7 | $94.1 | -16% |
NICE has finished lower in three of the last six years. It's down 16% so far in 2026.
PLTR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.20 | $27.8 | +202% |
| 2021 | $27.8 | $18.9 | -32% |
| 2022 | $18.9 | $6.29 | -67% |
| 2023 | $6.29 | $17.2 | +173% |
| 2024 | $17.2 | $79.1 | +361% |
| 2025 | $79.1 | $188.7 | +139% |
| 2026 YTD | $188.7 | $171.6 | -9.1% |
PLTR has the edge over NICE on returns for 2026, with the stronger performance.